{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-114800","form_type":"8-K","ticker":"INVA","cik":"0001080014","company_name":"Innoviva, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.598989+00:00","generated_at":"2026-05-30T04:18:23.923442+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Innoviva Q3 2024 royalty revenue $60.5M (+6% YoY); net product sales $27.8M; net income $1.2M","bullets":["Royalty revenue from GSK $60.5M, up 6% YoY; core royalty platform continued strong performance.","US net product sales $19.7M (+68% YoY) driven by GIAPREZA $13.1M, XACDURO $4.3M, XERAVA $2.3M.","Net income $1.2M ($0.02 basic EPS) vs $82.0M ($1.26) in Q3 2023; unfavorable $35.2M fair value change on Armata investment.","XACDURO nominated for Prix Galien USA Award; zoliflodacin NDA submission expected early 2025.","Cash and cash equivalents $260.6M; royalty and product sales receivables $91.1M as of Sep 30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-114800","json":"https://secwatch.observer/filing/0001104659-24-114800.json","markdown":"https://secwatch.observer/filing/0001104659-24-114800.md","text":"https://secwatch.observer/filing/0001104659-24-114800.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1080014/000110465924114800/0001104659-24-114800-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1080014/000110465924114800/tm2427621d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:18:23.923442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}